Sacral nerve stimulation for faecal incontinence and constipation in adults

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Thaha, Mohamed A ^a   Abukar, Amin A ^a   Thin, Noel N ^a   Ramsanahie, Anthony ^a   Knowles, Charles H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ANORECTAL PRESSURE; BLOATING; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONSTIPATION; FECES INCONTINENCE; HEMATOMA; HUMAN; INTESTINE MOTILITY; LEG PAIN; NERVE STIMULATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PERCUTANEOUS TIBIAL NERVE STIMULATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SACRAL NERVE STIMULATION; SEROMA; SKIN TINGLING; SYSTEMATIC REVIEW; URINARY TRACT DISEASE; WOUND INFECTION; ADVERSE EFFECTS; CROSSOVER PROCEDURE; ELECTRODE IMPLANT; ELECTROTHERAPY; FECAL INCONTINENCE; FEMALE; MALE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACRUM; SPINAL NERVE;

ADULT; CONSTIPATION; CROSS-OVER STUDIES; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FECAL INCONTINENCE; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; SACRUM; SPINAL NERVES;

EID: 84991271076     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004464.pub3     Document Type: Review

References (102)

1. Dinning PG, Hunt L, Patton V, Tzang T, Szczesniak M, Gebski V, et al. Treatment efficacy of sacral nerve stimulation in slow transit constipation: A two phase, double blind randomized controlled crossover study. American Journal of Gastroenterology 2015;110(5):733-40. [: sr-incont67952]
2. Kahlke V, Topic H, Peleikis HG, Jongen J. Sacral nerve modulation for fecal incontinence: results of a prospective single-center randomized crossover study. Diseases of the Colon & Rectum 2015;58:235-40. [: sr-incont66462]
3. Kenefick NJ. Sacral nerve neuromodulation for the treatment of lower bowel motility disorders. Annals of The Royal College of Surgeons of England 2006;88(7):617-23. [: 22235]
4. Kenefick NJ, Vaizey CJ, Cohen CR, Nicholls RJ, Kamm MA. Double-blind placebo-controlled crossover study of sacral nerve stimulation for idiopathic constipation. British Journal of Surgery 2002;89(12):1570-1. [: sr-incont16145]
5. Leroi AM, Parc Y, Lehur PA, Mion F, Barth X, Rullier E, et al. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Annals of Surgery 2005;242(5):662-9. [: sr-incont21269]
6. Sørensen M, Thomsen F. Sacral nerve stimulation increases rectal sensitivity in patients with faecal incontinence: results of a randomised double-blinded crossover study (Abstract number 437). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23-27, Toronto, Canada. 2010. [: sr-incont40174]
7. Thin NN, Taylor SJC, Bremner SA, Emmanuel AV, Hounsome N, Williams NS, et al. Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. British Journal of Surgery 2015;102(4):349-58. [: sr-incont66403]
8. Tjandra J, Lim J, Green C, Carey M. Sacral neuromodulation in patients with faecal incontinence: a randomized controlled study on efficacy and quality of life (Abstract number 090). Colorectal Disease 2005;7(Suppl 1):31. [: sr-incont24001]
9. Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: A randomized, controlled study. Diseases of the Colon and Rectum 2008;51(5):494-502. [: sr-incont27640]
10. Vaizey CJ, Kamm MA, Roy AJ, Nicholls RJ. Double-blind crossover study of sacral nerve stimulation for fecal incontinence. Diseases of the Colon & Rectum 2000;43(3):298-302. [: sr-incont11184]
11. Dinning PG, Fuentealba SE, Kennedy ML, Lubowski DZ, Cook IJ. Sacral nerve stimulation induces pan-colonic propagating pressure waves and increases defecation frequency in patients with slow-transit constipation. Colorectal Disease 2007;9(2):123-32. [: sr-incont22557]
12. Dinning P, Patton V, Hunt L, Gebski V, Jones M, Stewart P, Lubowski D, Cook I. Efficacy of sacral nerve stimulation for severe slow transit constipation: A randomised, double-blind, placebo-controlled, crossover study. Diseases of the Colon and Rectum 2013;56(4):e116. [: sr-incont49771]
13. Knowles CH, Thin N, Gill K, Bhan C, Grimmer K, Lunniss PJ, et al. Prospective randomized double-blind study of temporary sacral nerve stimulation in patients with rectal evacuatory dysfunction and rectal hyposensitivity. Annals of Surgery 2012;255(4):643-9. [: sr-incont45223]
14. Borjesson L. Sacral nerve stimulation vs anal bulking for faecal incontinence - a randomised controlled trial. http://isrctn.org/ISRCTN00247992 2013. [: sr-incont64540]
15. Jayne D. Safari: Sacral nerve stimulation versus the FENIX TM magnetic sphincter augmentation for adult faecal incontinence: a prospective, UK multi-site, parallel-group, randomised clinical study investigating the safety and efficacy of the FENIX TM magnetic sphincter augmentation (MSA) compared to sacral nerve stimulation (SNS) for adult FI. http://isrctn.org/ISRCTN16077538 2014. [: sr-incont64510]
16. Vallance A, Brown S, Nugent K, Lodge J, Protheroe D, Neville K, et al. Study design: Sacral nerve stimulation versus the FENIXTM magnetic anal sphincter for adult faecal incontinence: A randomised investigation (SaFaRI) (Abstract number W191). Colorectal Disease 2014;16(Suppl s2):197. [: sr-incont66262]
17. Altomare DF, Binda GA, Dodi G, La Torre F, Romano G, Rinaldi M, et al. Disappointing long-term results of the artificial anal sphincter for faecal incontinence. The British Journal of Surgery 2004;91(10):1352-3.
18. Baeten CG, Konsten J, Soeters PB, Spaans F, Visser R, Habets AM, et al. Dynamic graciloplasty for treatment of faecal incontinence. Lancet 1991;338(8776):1163-5.
19. Baeten CG, Geerdes BP, Adang EM, Heineman E, Konsten J, Engel GL, et al. Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. The New England Journal of Medicine 1995;332(24):1600-5.
20. Brindley GS. Emptying the bladder by stimulating sacral ventral roots. The Journal of Physiology 1974;237(2):15-6.
21. Brown SR, Wadhawan H, Nelson RL. Surgery for faecal incontinence in adults. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD001757.pub4]
22. Burgell RE, Bhan C, Lunniss PJ, Scott SM. Fecal incontinence in men: coexistent constipation and impact of rectal hyposensitivity. Diseases of the Colon & Rectum 2012;55(1):18-25.
23. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. The New England Journal of Medicine 2008;358(22):2344-54.
24. Carr LK, Robert M, Kultgen PL, Herschorn S, Birch C, Murphy M, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. The Journal of Urology 2013;189(2):595-601.
25. Carrington EV, Knowles CH. The influence of sacral nerve stimulation on anorectal dysfunction. Colorectal Disease 2011;13(Suppl 2):5-9.
26. Carrington EV, Evers J, Grossi U, Dinning PG, Scott SM, O'Connell PR, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterology & Motility 2014;26(9):1222-37.
27. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterology & Motility 2009;21(Suppl 2):1-8.
28. Dinning PG, Hunt LM, Arkwright JW, Patton V, Szczesniak MM, Wiklendt L, et al. Pancolonic motor response to subsensory and suprasensory sacral nerve stimulation in patients with slow-transit constipation. British Journal of Surgery 2012;99(7):1002-10.
29. Dudding TC, Meng Lee E, Faiz O, Pares D, Vaizey CJ, McGuire A, et al. Economic evaluation of sacral nerve stimulation for faecal incontinence. The British Journal of Surgery 2008;95(9):1155-63.
30. Duelund-Jakobsen J, Buntzen S, Lundby L, Laurberg S. Sacral nerve stimulation at subsensory threshold does not compromise treatment efficacy: results from a randomized, blinded crossover study. Annals of Surgery 2013;257(2):219-23.
31. Ehrenpreis ED, Chang D, Eichenwald E. Pharmacotherapy for fecal incontinence: a review. Diseases of the Colon & Rectum 2007;50(5):641-9.
32. Enck P, Van der Voort IR, Klosterhalfen S. Biofeedback therapy in fecal incontinence and constipation. Neurogastroenterology & Motility 2009;21(11):1133-41.
33. Evers J, Devane L, Carrington EV, Scott SM, Knowles CH, O'Connell PR, et al. Effects of stimulation frequency and intensity in sacral neuromodulation on anorectal inputs to the somatosensory cortex in an experimental model. British Journal of Surgery 2014;101(10):1317-28.
34. Food, Drug Administration. Medtronic, Inc.; premarket approval of the Interstim Sacral Nerve Stimulation (SNS) System--FDA. Notice. Federal register 1998;63(19):4457.
35. Fraser C, Glazener C, Grant A, Mowatt G. Systematic review of the efficacy and safety of sacral nerve stimulation for faecal incontinence. Available at: http://www.nice.org.uk/guidance/ipg99/resources/systematic-review-of-the-efficacy-and-safety-of-sacral-nerve-stimulation-for-faecal-incontinence2 (accessed 12 December 2014) 2004.
36. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Chronic constipation in the elderly. The American Journal of Gastroenterology 2012;107(1):18-25; quiz 26.
37. Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 2011;377(9770):997-1003.
38. Griffin KM, Pickering M, O'Herlihy C, O'Connell PR, Jones JF. Sacral nerve stimulation increases activation of the primary somatosensory cortex by anal canal stimulation in an experimental model. British Journal of Surgery 2011;98(8):1160-9.
39. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Holzer B, Rosen HR, Novi G, Ausch C, Hölbling N, Hofmann M, et al. Sacral nerve stimulation in patients with severe constipation. Diseases of the Colon & Rectum 2008;51(5):524-29; discussion 529-30.
41. Hopkinson BR, Lightwood R. Electrical treatment of anal incontinence. Lancet 1966;1(7432):297-8.
42. Hotouras A, Murphy J, Walsh U, Allison M, Curry A, Williams NS, et al. Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal incontinence: a prospective cohort study. Annals of Surgery 2014;259(5):939-43.
43. Health and Social Care Information Centre. Prescriptions Dispensed in the Community: England 2002-12. http://www.hscic.gov.uk/catalogue/PUB11291/pres-disp-com-eng-2002-12-rep.pdf 2013.
44. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. The American Journal of Gastroenterology 2002;97(8):1986-93.
45. Jarrett MED, Mowatt G, Glazener CMA, Fraser C, Nicholls RJ, Grant AM, et al. Systematic review of sacral nerve stimulation for faecal incontinence and constipation. British Journal of Surgery 2004;91(12):1559-69.
46. Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. The American Journal of Gastroenterology 1996;91(1):33-6.
47. Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. The American Journal of Gastroenterology 2008;103(1):170-7.
48. Kamm MA, Dudding TC, Melenhorst J, Jarrett M, Wang Z, Buntzen S, et al. Sacral nerve stimulation for intractable constipation. Gut 2010;59(3):333-40.
49. Knowles CH, Scott M, Lunniss PJ. Outcome of colectomy for slow transit constipation. Annals of Surgery 1999;230(5):627-38.
50. Knowles CH, Scott SM, Rayner C, Glia A, Lindberg G, Kamm MA, et al. Idiopathic slow-transit constipation: an almost exclusively female disorder. Diseases of the Colon & Rectum 2003;46(12):1716-7.
51. Knowles CH, Dinning PG, Pescatori M, Rintala R, Rosen H. Surgical management of constipation. Neurogastroenterology & Motility 2009;21(Suppl 2):62-71.
52. Lehur PA, Glemain P, Bruley des Varannes S, Buzelin JM, Leborgne J. Outcome of patients with an implanted artificial anal sphincter for severe faecal incontinence. A single institution report. International Journal of Colorectal Disease 1998;13(2):88-92.
53. Lehur PA, McNevin S, Buntzen S, Mellgren AF, Laurberg S, Madoff RD. Magnetic anal sphincter augmentation for the treatment of fecal incontinence: a preliminary report from a feasibility study. Diseases of the Colon & Rectum 2010;53(12):1604-10.
54. Lunniss PJ, Gladman MA, Hetzer FH, Williams NS, Scott SM. Risk factors in acquired faecal incontinence. Journal of the Royal Society of Medicine 2004;97(3):111-6.
55. MacDonagh RP, Sun WM, Smallwood R, Forster D, Read NW. Control of defecation in patients with spinal injuries by stimulation of sacral anterior nerve roots. British Medical Journal 1990;300(6738):1494-7.
56. Maeda Y, Lundby L, Buntzen S, Laurberg S. Sacral nerve stimulation for constipation: suboptimal outcome and adverse events. Diseases of the Colon & Rectum 2010;53(7):995-9.
57. Malouf AJ, Norton CS, Engel AF, Nicholls RJ, Kamm MA. Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet 2000;355(9200):260-5.
58. Matzel KE, Schmidt RA, Tanagho EA. Neuroanatomy of the striated muscular anal continence mechanism. Implication for the use of neurostimulation. Diseases of the Colon & Rectum 1990;33:666-673.
59. Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet 1995;346(8983):1124-7.
60. McCrea GL, Miaskowski C, Stotts NA, Macera L, Paul SM, Varma MG. Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation. Gender Medicine 2009;6(1):259-71.
61. Melenhorst J, Koch SM, Uludag O, van Gemert WG, Baeten CG. Sacral neuromodulation in patients with faecal incontinence: results of the first 100 permanent implantations. Colorectal Disease 2007;9(8):725-30.
62. Mitchell PJ, Cattle K, Saravanathan S, Telford KJ, Kiff ES. Insertion under local anaesthetic of temporary electrodes for sacral nerve stimulation testing is reliable and cost effective. Colorectal Disease 2011;13(4):445-8.
63. Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Practice & Research: Clinical Gastroenterology 2011;25(1):3-18.
64. Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Diseases of the Colon & Rectum 1998;41(10):1226-9.
65. Nelson RL. Epidemiology of fecal incontinence. Gastroenterology 2004;126(1 Suppl1):S3-7.
66. National Health Service. Constipation - suspected. http://healthguides.mapofmedicine.com/choices/map/constipation_in_adults_and_the_elderly1.html 2012.
67. National Health Service (NHS) England. A08/S/d 2013/14 NHS standard contract for colorectal: faecal incontinence (adult). Available at: http://www.england.nhs.uk/wp-content/uploads/2013/06/a08-colore-faecal-incon-adult.pdf (accessed 21 May 2014) 2013:1-7.
68. National Institute for Health and Care Excellence. Faecal incontinence: The management of faecal incontinence in adults. http://www.nice.org.uk/nicemedia/live/11012/36582/36582.pdf 2007.
69. Norton C, Chelvanayagam S, Wilson-Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003;125(5):1320-9.
70. Norton C. Behavioral management of fecal incontinence in adults. Gastroenterology 2004;126(1 Suppl 1):S64-70.
71. Norton C. Constipation in older patients: effects on quality of life. British Journal of Nursing 2006;15(4):188-92.
72. Norton C, Thomas L, Hill J. Management of faecal incontinence in adults: summary of NICE guidance. British Medical Journal 2007;334(7608):1370-1.
73. Omar MI, Edwin C. Drug treatment for faecal incontinence in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD002116.pub2]
74. Otto SD, Burmeister S, Buhr HJ, Kroesen A. Sacral nerve stimulation induces changes in the pelvic floor and rectum that improve continence and quality of life. Journal of Gastrointestinal Surgery 2010;14(4):636-44.
75. Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. British Journal of Surgery 2013;100(7):959-68.
76. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143(5):1179-87 e1-3.
77. Poulton B, Thomas S. The Nursing Cost of Constipation. Primary Health Care 1999;9(9):17-22.
78. Probert CS, Emmett PM, Heaton KW. Some determinants of whole-gut transit time: a population-based study. QJM 1995;88(5):311-5.
79. Rao SS. Pathophysiology of adult fecal incontinence. Gastroenterology 2004;126(1 Suppl1):S14-22.
80. Rao SS. Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. The American Journal of Gastroenterology 2004;99(8):1585-604.
81. Ratto C, Parello A, Donisi L, Litta F, De Simone V, Spazzafumo L, et al. Novel bulking agent for faecal incontinence. The British Journal of Surgery 2011;98(11):1644-52.
82. Thomson Reuters. Reference Manager Professional Edition Version 12. New York: Thomson Reuters, 2012.
83. Scott SM, van den Berg MM, Benninga MA. Rectal sensorimotor dysfunction in constipation. Best Practice & Research: Clinical Gastroenterology 2011;25(1):103-18.
84. Sharma A, Bussen D, Herold A, Jayne D. Review of Sacral Neuromodulation for Management of Constipation. Surgical Innovation 2013;20(6):614-624.
85. Sonnenberg A, Koch TR. Epidemiology of constipation in the United States. Diseases of the Colon & Rectum 1989;32(1):1-8.
86. Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. The American Journal of Gastroenterology 1999;94(12):3530-40.
87. Sultan AH, Kamm MA, Hudson CN, Thomas JM, Bartram CI. Anal-sphincter disruption during vaginal delivery. The New England Journal of Medicine 1993;329(26):1905-11.
88. Sultan AH, Kamm MA. Faecal incontinence after childbirth. British Journal of Obstetrics and Gynaecology 1997;104(9):979-82.
89. Sultan AH, Monga AK. Anal and urinary incontinence in women with obstetric anal sphincter rupture. British Journal of Obstetrics and Gynaecology 1997;104(6):754-5.
90. Tan E, Ngo NT, Darzi A, Shenouda M, Tekkis PP. Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence. International Journal of Colorectal Disease 2011;26:275-94.
91. Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. The Journal of Urology 1989;142(2 Pt 1):340-5.
92. Thin NN, Horrocks EJ, Hotouras A, Palit S, Thaha MA, Chan CL, et al. Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. The British Journal of Surgery 2013;100(11):1430-47.
93. Tjandra JJ, Lim JF, Matzel K. Sacral nerve stimulation: an emerging treatment for faecal incontinence. ANZ Journal of Surgery 2004;74(12):1098-106.
94. Vaizey CJ. Faecal incontinence: standardizing outcome measures. Colorectal Disease 2014;16(3):156-8.
95. van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. The American Journal of Gastroenterology 2006;101(10):2401-9.
96. Vitton V, Roman S, Damon H, Barth X, Mion F. Sacral nerve stimulation and constipation: still a long way to go. Diseases of the Colon & Rectum 2009;52(4):752-3; author reply 753-4.
97. Wald A, Scarpignato C, Mueller-Lissner S, Kamm MA, Hinkel U, Helfrich I, et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Alimentary Pharmacology & Therapeutics 2008;28(7):917-30.
98. Wexner SD, Coller JA, Devroede G, Hull T, McCallum R, Chan M, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Annals of Surgery 2010;251(3):441-9.
99. Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009;137(2):512-7, 517 e1-2.
100. Wong MT, Meurette G, Rodat F, Regenet N, Wyart V, Lehur PA. Outcome and management of patients in whom sacral nerve stimulation for fecal incontinence failed. Diseases of the Colon & Rectum 2011;54(4):425-32.
101. Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD008486.pub2]
102. Mowatt G, Glazener C, Jarrett M. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD004464.pub2]